Managed care
Pediatric Associates, P.A.
Pediatric Associates, P.A. was paid $7.60M by Medicaid between Jan 2018 and Dec 2024, across 72 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoPEDIATRIC ASSOCIATES, P.A.
COLUMBIA, SC 29204
COLUMBIA, SC 29204
33aNPI1447383666assigned 03/14/2007
33bProvider typePreferred Provider Organization
28Total paid$7.60M
24GClaims229,408
24DCodes billed72
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Preferred Provider Organization providers in South Carolina
Rank by total paid#1 of 7
Median peer was paid$452K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,963 | $888K | |
| 2019 | 29,342 | $829K | |
| 2020 | 27,806 | $830K | |
| 2021 | 36,823 | $1.24M | |
| 2022 | 37,540 | $1.32M | |
| 2023 | 35,354 | $1.34M | |
| 2024incomplete | 27,580 | $1.16M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 38,622 | 34,356 | $2.49M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 11,184 | 10,264 | $1.04M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 10.0% | 16,927 | 16,619 | $759K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.4% | 6,444 | 6,387 | $640K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.5% | 6,171 | 6,049 | $567K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.1% | 3,881 | 3,843 | $385K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.9% | 5,628 | 4,873 | $219K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.7% | 1,864 | 1,852 | $202K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.2% | 3,316 | 3,202 | $164K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 11,595 | 11,063 | $148K |
| 90461 | 1.9% | 6,576 | 6,392 | $141K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.6% | 1,650 | 1,582 | $125K |
60 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 13,256 | $96K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 5,635 | $81K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 9,577 | $75K |
| 36415 | Collection of venous blood by venipuncture | <1% | 19,941 | $47K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,122 | $43K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 345 | $41K |
| 99050 | <1% | 3,600 | $40K | |
| 96127 | <1% | 4,626 | $37K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 534 | $34K |
| 87081 | <1% | 4,522 | $28K | |
| 85018 | <1% | 10,378 | $25K | |
| 96160 | <1% | 3,346 | $20K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,080 | $20K |
| 81003 | <1% | 8,591 | $19K | |
| 87634 | <1% | 283 | $16K | |
| 87430 | <1% | 952 | $14K | |
| 83655 | <1% | 1,073 | $14K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 155 | $8K |
| 82465 | <1% | 2,046 | $8K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 76 | $7K |
| 87807 | <1% | 684 | $7K | |
| 99223 | Prolong inpt eval add15 m | <1% | 38 | $7K |
| 90677 | <1% | 666 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,585 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 503 | $5K |
| 99460 | <1% | 51 | $4K | |
| G9153 | Mapcp demonstration - physician incentive pool | <1% | 95 | $4K |
| 94664 | <1% | 228 | $2K | |
| 0071A | <1% | 65 | $2K | |
| 0072A | <1% | 43 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 956 | $1K |
| 0002A | <1% | 29 | $870.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 32 | $776.14 |
| 90686 | <1% | 4,331 | $529.23 | |
| 90380 | <1% | 17 | $511.43 | |
| 94760 | <1% | 329 | $463.21 | |
| 69210 | <1% | 12 | $457.34 | |
| 87301 | <1% | 47 | $413.47 | |
| 0003A | <1% | 13 | $390.00 | |
| 99058 | <1% | 13 | $325.00 | |
| 82247 | <1% | 61 | $291.22 | |
| 90723 | <1% | 2,745 | $186.32 | |
| 90633 | <1% | 1,707 | $104.97 | |
| 90656 | <1% | 237 | $77.16 | |
| 90648 | <1% | 3,226 | $48.52 | |
| 91307 | <1% | 150 | $2.59 | |
| 91300 | <1% | 36 | $0.35 | |
| 90696 | 0% | 69 | $0.00 | |
| 36416 | 0% | 1,332 | $0.00 | |
| 90651 | 0% | 164 | $0.00 | |
| 90716 | 0% | 118 | $0.00 | |
| 90620 | 0% | 13 | $0.00 | |
| 90670 | 0% | 3,333 | $0.00 | |
| 90734 | 0% | 248 | $0.00 | |
| 90681 | 0% | 964 | $0.00 | |
| 90707 | 0% | 93 | $0.00 | |
| 90700 | 0% | 41 | $0.00 | |
| 90710 | 0% | 85 | $0.00 | |
| 90715 | 0% | 25 | $0.00 | |
| 90685 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCASTLES, CHARLES (PRESIDENT)